Europe Bioinformatics Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Bioinformatics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Bioinformatics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Funding and Investments in Bioinformatics
5.1.2 Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics

5.2 Market Opportunities

5.2.1 Rising Demand for Personalized Medicine

5.3 Future Trends

5.3.1 Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics

5.4 Impact of Drivers and Restraints

6. Europe Bioinformatics Market Regional Analysis

6.1 Europe Bioinformatics Market Overview

6.2 Europe Bioinformatics Market Revenue 2020-2028 (US$ Million)

6.3 Europe Bioinformatics Market Forecast Analysis

7. Europe Bioinformatics Market Analysis – by Product

7.1 Knowledge Management Tools

7.1.1 Overview
7.1.2 Knowledge Management Tools: Europe Bioinformatics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Bioinformatics Platforms

7.2.1 Overview
7.2.2 Bioinformatics Platforms: Europe Bioinformatics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Bio Informative Services

7.3.1 Overview
7.3.2 Bio Informative Services: Europe Bioinformatics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Bioinformatics Market Analysis – by Application

8.1 Genomics

8.1.1 Overview
8.1.2 Genomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Chemo Informatics and Drug Design

8.2.1 Overview
8.2.2 Chemo Informatics and Drug Design: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Proteomics

8.3.1 Overview
8.3.2 Proteomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Transcriptomics

8.4.1 Overview
8.4.2 Transcriptomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Metabolomics

8.5.1 Overview
8.5.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Bioinformatics Market Analysis – by Sector

9.1 Medical Biotechnology

9.1.1 Overview
9.1.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Academics

9.2.1 Overview
9.2.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Animal Biotechnology

9.3.1 Overview
9.3.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Agricultural Biotechnology

9.4.1 Overview
9.4.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Environmental Biotechnology

9.5.1 Overview
9.5.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Forensic Biotechnology

9.6.1 Overview
9.6.2 Metabolomics: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Bioinformatics Market – Europe Analysis

10.1 Europe

10.1.1 Europe Bioinformatics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Europe Bioinformatics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Bioinformatics Market Breakdown, by Product
10.1.1.1.2 UK: Europe Bioinformatics Market Breakdown, by Application
10.1.1.1.3 UK: Europe Bioinformatics Market Breakdown, by Sector

10.1.1.2 Germany: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Bioinformatics Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Bioinformatics Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Bioinformatics Market Breakdown, by Sector

10.1.1.3 France: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Bioinformatics Market Breakdown, by Product
10.1.1.3.2 France: Europe Bioinformatics Market Breakdown, by Application
10.1.1.3.3 France: Europe Bioinformatics Market Breakdown, by Sector

10.1.1.4 Russia: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Bioinformatics Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Bioinformatics Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Bioinformatics Market Breakdown, by Sector

10.1.1.5 Italy: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Bioinformatics Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Bioinformatics Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Bioinformatics Market Breakdown, by Sector

10.1.1.6 Rest of Europe: Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Bioinformatics Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Bioinformatics Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Bioinformatics Market Breakdown, by Sector

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Bioinformatics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Biomax Informatics AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bruker Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Dassault Systèmes

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Eurofins Scientific

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Genebio

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Illumina, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 PerkinElmer Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 QIAGEN

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights